Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Radient Pharmaceuticals Corporation (RXPC) - Financial and Strategic SWOT Analysis Review
Publication Date Jan 2014
Product Type Report
Pages 38
Single User License help $ 125.00
Site User License help $ 250.00
Corporate User License help $ 375.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Radient Pharmaceuticals Corporation (RXPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Radient Pharmaceuticals Corporation (Radient Pharma) formerly AMDL, Inc. is an in-vitro diagnostics (IVD) company. It carries out the development, manufacture and marketing of medical diagnostic and monitoring products. The company’s flagship product, Onko-Sure test is a proprietary IVD cancer test. It offers screening, monitoring and detection of 19 or more types of cancers. The company also commercializes a proprietary cancer vaccine therapy technology: Combined Immunogene Therapy (CIT). Radient Pharma manufactures its tests in its FDA approved GMP manufacturing facility.

Radient Pharmaceuticals Corporation Key Recent Developments

Jan 24, 2012: Radient Pharma Introduces Its 2012 Sales, Advertising And Outreach Plan Presentation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Radient Pharmaceuticals Corporation - Key Facts 5
Radient Pharmaceuticals Corporation - Key Employees 6
Radient Pharmaceuticals Corporation - Key Employee Biographies 7
Radient Pharmaceuticals Corporation - Major Products and Services 8
Radient Pharmaceuticals Corporation - Medical Equipment Pipeline Products Data 9
Radient Pharmaceuticals Corporation Pipeline Products by Equipment Type 9
Radient Pharmaceuticals Corporation Pipeline Products by Development Stage 11
Radient Pharmaceuticals Corporation - History 13
Radient Pharmaceuticals Corporation - Company Statement 15
Radient Pharmaceuticals Corporation - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Radient Pharmaceuticals Corporation - Business Description 17
Radient Pharmaceuticals Corporation - Corporate Strategy 18
Radient Pharmaceuticals Corporation - SWOT Analysis 19
SWOT Analysis - Overview 19
Radient Pharmaceuticals Corporation - Strengths 19
Strength - Strategic Agreements 19
Strength - Technological Capabilities 19
Radient Pharmaceuticals Corporation - Weaknesses 19
Weakness - History of Losses 19
Weakness - Litigation Claims 20
Radient Pharmaceuticals Corporation - Opportunities 20
Opportunity - Lead Product Onko-Sure 20
Opportunity - Growing Clinical Laboratory Testing Industry 20
Opportunity - Market Growth in Emerging Economies 20
Radient Pharmaceuticals Corporation - Threats 20
Threat - Intense Competition 20
Threat - Stringent Government Regulations 21
Threat - Rapid Technological Changes 21
Radient Pharmaceuticals Corporation - Key Competitors 22
Section 3 – Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 23
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Radient Pharmaceuticals Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 28
Radient Pharmaceuticals Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013 29
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Radient Pharmaceuticals Corporation, Recent Deals Summary 32
Section 5 – Company’s Recent Developments 33
Radient Pharmaceuticals Corporation, Recent Developments 33
Jan 24, 2012: Radient Pharma Introduces Its 2012 Sales, Advertising And Outreach Plan Presentation 33
Section 6 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
List of Tables
Radient Pharmaceuticals Corporation, Key Facts 5
Radient Pharmaceuticals Corporation, Key Employees 6
Radient Pharmaceuticals Corporation, Key Employee Biographies 7
Radient Pharmaceuticals Corporation, Major Products and Services 8
Radient Pharmaceuticals Corporation Number of Pipeline Products by Equipment Type 9
Radient Pharmaceuticals Corporation Pipeline Products by Equipment Type 10
Radient Pharmaceuticals Corporation Number of Pipeline Products by Development Stage 11
Radient Pharmaceuticals Corporation Pipeline Products by Development Stage 12
Radient Pharmaceuticals Corporation, History 13
Radient Pharmaceuticals Corporation, Subsidiaries 16
Radient Pharmaceuticals Corporation, Key Competitors 22
Radient Pharmaceuticals Corporation, Ratios based on current share price 23
Radient Pharmaceuticals Corporation, Annual Ratios 23
Radient Pharmaceuticals Corporation, Interim Ratios 26
Radient Pharmaceuticals Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 28
Radient Pharmaceuticals Corporation, Medical Equipment, Deals By Type, 2007 to YTD 2013 29
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 31
Radient Pharmaceuticals Corporation, Recent Deals Summary 32
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
List of Figures
Radient Pharmaceuticals Corporation Pipeline Products by Equipment Type 9
Radient Pharmaceuticals Corporation Pipeline Products by Development Stage 11
Radient Pharmaceuticals Corporation, Performance Chart (2007 - 2011) 25
Radient Pharmaceuticals Corporation, Ratio Charts 27
Radient Pharmaceuticals Corporation, Medical Equipment, Deals By Year, 2007 to YTD 2013 28
Radient Pharmaceuticals Corporation, Medical Equipment, Deals by Type, 2007 to YTD 2013 29
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 30
Radient Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 31

Title Date Price
2017-2022 False Lashes Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
By QYResearch
This report studies the False Lashes market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in g ...Read More
Mar 2017 $2960.00
Alkem Laboratories Ltd. - Strategic SWOT Analysis Review
By GlobalData
Alkem Laboratories Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a det ...Read More
Jan 2014 $125.00
American International Industries : Consumer Packaged Goods - Company Profile, SWOT and Financial Report
By GlobalData
SynopsisCanadean's "American International Industries : Consumer Packaged Goods - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. ...Read More
Jun 2014 $125.00
Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has b ...Read More
Jan 2014 $125.00
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review
By GlobalData
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been comp ...Read More
Jan 2014 $125.00
Apollo Hospitals Enterprise Limited (APOLLOHOSP) - Financial and Strategic SWOT Analysis Review
By GlobalData
Apollo Hospitals Enterprise Limited (APOLLOHOSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profi ...Read More
Jan 2014 $125.00
Asia Sunscreen Cream Original Equipment Manufacturer (OEM) & Brands Market 2015-2021
By QYResearch
This report studies the Asia Sunscreen Cream Original Equipment Manufacturer (OEM) & Brands market, focuses on the future price trend, sales trend, and applications in Asia and major regions. Market ...Read More
Jun 2016 $3150.00
Asia-Pacific Anti Acne Cleanser Market Report 2017
By QYResearch
In this report, the Asia-Pacific Anti Acne Cleanser market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 202 ...Read More
Apr 2017 $4000.00
Asia-Pacific Anti Acne Mask Market Report 2017
By QYResearch
In this report, the Asia-Pacific Anti Acne Mask market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. ...Read More
Apr 2017 $4000.00
Asia-Pacific Body Scrub Market Report 2017
By QYResearch
In this report, the Asia-Pacific Body Scrub market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geog ...Read More
May 2017 $4000.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z